CHS Acquires product lines from Roxon Medi-Tech Ltd.

Tuesday February 16, 2021

Canadian Hospital Specialties Limited (CHS) is pleased to announce the acquisition of all product lines from Roxon Medi-Tech Ltd., excluding Urology products, which will remain with Roxon Medi-Tech Ltd.  

 

CHS is one of Canada’s best known and successful medical device manufacturers and specialty distributors of products covering Interventional Radiology, Perfusion, Respiratory, Anesthesia, Operating Room, Diagnostic Imaging, Pharmacy, General Medicine, and Critical Care.

 

The acquisition of the Roxon product lines will broaden CHS’s footprint in the Cardiac Diagnostics and Monitoring and Neuro Monitoring spaces.  It also adds a Pulmonary testing portfolio to the existing Respiratory platform and augments the existing Pharmacy portfolio for both the acute and non-acute channel with the refrigeration portfolio. 

 

Please join CHS in welcoming the Roxon employees to the CHS family.

 

Please contact your local CHS representative or existing Roxon representative for more details.


Do you like this story?


Back to news list